[

sii

]
The SII CEO told ‘The Times’ in an interview about receiving aggressive calls from some of the most powerful people in India, demanding supplies of Covishield -- the Oxford/AstraZeneca Covid-19 vaccine that the Serum Institute is producing in India.(Bloomberg)

'Everything falls on my shoulders': Adar Poonawalla on vaccine pressure in India

PTI | | Posted by Prashasti Singh, London
PUBLISHED ON MAY 01, 2021 06:37 PM IST
“I’m staying here (London) for an extended time because I don't want to go back to that situation. Everything falls on my shoulders but I can't do it alone...,” Poonawalla said.
Front line workers at a vaccination centre in Chennai. (PTI)
Front line workers at a vaccination centre in Chennai. (PTI)

120 million doses ordered as vaccine urgency deepens

By Anonna Dutt, Hindustan Times, New Delhi
UPDATED ON MAR 21, 2021 06:33 AM IST
Of the 120 million doses, 100 million will be of Covishield being manufactured by SII. The remaining will be of Covaxin by Bharat Biotech. The two are the only vaccines approved in India till now for use among people.
Adar Poonawalla, chief executive officer of Serum Institute of India Ltd., at the company's Hadapsar plant in Pune, Maharashtra. (Bloomberg)
Adar Poonawalla, chief executive officer of Serum Institute of India Ltd., at the company's Hadapsar plant in Pune, Maharashtra. (Bloomberg)

Serum CEO Poonawalla says vaccine nationalism threatens poorer nations

Bloomberg |
UPDATED ON MAR 17, 2021 05:34 AM IST
Countries are holding tight to their supplies and restricting access to materials needed to make more, said Adar Poonawalla, chief executive officer of the Serum Institute of India Ltd.
Workers transfer carton boxes of a Covishield vaccine developed by Pune based Serum Institute of India (SII) that arrived in a truck into the Karnataka Health Department cold storage facility in Bangalore. (AFP)
Workers transfer carton boxes of a Covishield vaccine developed by Pune based Serum Institute of India (SII) that arrived in a truck into the Karnataka Health Department cold storage facility in Bangalore. (AFP)

SII to supply 1.1 billion doses of Covid-19 vaccines to Covax vaccine scheme

Reuters | , Geneva/london
PUBLISHED ON FEB 03, 2021 07:45 PM IST
UNICEF chief Henrietta Fore said the shots would be delivered over a number of years at the cost of about $3 per dose for low- and middle-income countries.
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)
Maharashtra Chief Minister Uddhav Thackeray speaks as he attends a meeting through video conferencing in Mumbai. (ANI Photo)

SII fire accident or sabotage to be known after probe, says Uddhav Thackeray

PTI |
PUBLISHED ON JAN 22, 2021 06:15 PM IST
Five men died in the fire that broke out in a five- storeyed under-construction building in the SII's Manjari premises in Pune on Thursday.
A smoke rises from fire at Serum Institute of India in Pune, India January 21, 2021. REUTERS/Stringer(REUTERS)
A smoke rises from fire at Serum Institute of India in Pune, India January 21, 2021. REUTERS/Stringer(REUTERS)

Damage in fire worth 1K crore, Covid vaccine supply not to be impacted: SII CEO

Written by Prashasti Singh, New Delhi
UPDATED ON JAN 22, 2021 06:22 PM IST
In a statement issued earlier, SII officials had said the fire would impact the production of BCG and Rotavirus vaccines in future.
Workers wearing protective gear walk after a fire broke out at India's Serum Institute in Pune on January 21, 2021. (AFP)
Workers wearing protective gear walk after a fire broke out at India's Serum Institute in Pune on January 21, 2021. (AFP)

5 killed in fire at Pune's Serum Institute’s Manjari plant

By hindustantimes.com | Edited by Arpan Rai
UPDATED ON JAN 21, 2021 07:02 PM IST
"Four people were evacuated from the building but when it came under control, five bodies were found by our jawans," Pune Mayor Murlidhar Mohol told news agency ANI.
Pune's Mayor Murlidhar Mohol said a call was received at 2.50pm following which 10 fire tenders and at least two extra tankers were rushed to the spot.
Pune's Mayor Murlidhar Mohol said a call was received at 2.50pm following which 10 fire tenders and at least two extra tankers were rushed to the spot.

Fire at SII's Manjri plant in Pune: 'No loss of life', tweets Adar Poonawalla

Written by Prashasti Singh, New Delhi
UPDATED ON JAN 21, 2021 04:48 PM IST
The fire was reported on the fifth floor of SII's Manjri plant, where BCG vaccine-related work was underway.
The gravity of the moment dawned upon the drivers of the trucks as the crowd present at the gates erupted in spontaneous applause that pierced the silence of the morning
The gravity of the moment dawned upon the drivers of the trucks as the crowd present at the gates erupted in spontaneous applause that pierced the silence of the morning

As vaccine trucks leave Serum campus, India starts fight to end Covid in country

By Shalaka Shinde, Steffy Thevar, Pune
UPDATED ON JAN 12, 2021 10:44 PM IST
At the stroke of 4:53 am, the gates opened, a police escort van remerged; it was followed by three trucks, with boxes carrying 5.65 million doses of the vaccine meant for Delhi, Chennai, Ahmedabad, Hyderabad, Chandigarh, Kolkata, Patna, Bengaluru, and Lucknow.
HT Image
HT Image

Application in Pune court against trade mark of “Covishield”

Hindustan Times, Pune | By Shalaka Shinde, Pune
PUBLISHED ON JAN 05, 2021 11:37 PM IST
Currently, there are 45 candidate vaccines in clinical evaluation and 156 candidate vaccines in pre-clinical evaluation, the WHO scientists said(REUTERS)
Currently, there are 45 candidate vaccines in clinical evaluation and 156 candidate vaccines in pre-clinical evaluation, the WHO scientists said(REUTERS)

Speedy distribution of Covid-19 vaccine a major challenge for global govts: WHO experts

Thiruvananthapuram | By Press Trust of India | Posted by Ayshee Bhaduri
PUBLISHED ON JAN 05, 2021 05:13 PM IST
his daunting challenge is not only for India but also for all the governments across the globe as they start inoculating their populations to tackle the pandemic, noted Dr Soumya Swaminathan, Chief Scientist of WHO, and Dr Hamsadvani Kuganantham, Consultant, WHO.
Health workers and candidate during Covid-19 vaccine dry run at District Hospital, Aundh, in Pune.(Pratham Gokhale/HT Photo)
Health workers and candidate during Covid-19 vaccine dry run at District Hospital, Aundh, in Pune.(Pratham Gokhale/HT Photo)

Will provide global access to our Covid-19 vaccines, Serum Institute and Bharat Biotech in joint pledge

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Shankhyaneel Sarkar
UPDATED ON JAN 05, 2021 04:11 PM IST
SII and Bharat Biotech said they are fully aware of the importance of vaccines for people across the world.
An employee in personal protective equipment removes vials of SII's Covishield from a visual inspection machine.(REUTERS)
An employee in personal protective equipment removes vials of SII's Covishield from a visual inspection machine.(REUTERS)

India’s Covid-19 vaccine export ban excludes Bangladesh: Minister

Dhaka | By Press Trust of India | Posted by Kunal Gaurav
UPDATED ON JAN 04, 2021 10:39 PM IST
Bangladesh Foreign Minister Dr A K Abdul Momen said that the first consignment of the vaccine co-manufactured by India’s SII is expected to reach the country towards the end of this month.
A view of Humayun's Tomb after morning rain in New Delhi, India, on Sunday, January 3, 2021.(Amal KS/HT PHOTO)
A view of Humayun's Tomb after morning rain in New Delhi, India, on Sunday, January 3, 2021.(Amal KS/HT PHOTO)

News updates from Hindustan Times: Heavy rain with thunderstorm, lightning likely over northwest India till Tuesday and all the latest news

Hindustan Times, New Delhi | By HT Correspondent
PUBLISHED ON JAN 04, 2021 09:20 AM IST
Here are today’s top news, analysis, and opinion at 9 am. Know all about the latest news and other news updates from Hindustan Times.
Adar Poonawalla, chief executive officer (CEO) of the Serum Institute of India at the Serum Institute of India, Pune, India.(Reuters)
Adar Poonawalla, chief executive officer (CEO) of the Serum Institute of India at the Serum Institute of India, Pune, India.(Reuters)

‘Can deliver vaccines 7-10 days after purchase order’: Adar Poonawalla

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON JAN 04, 2021 05:48 AM IST
“We wanted the drugs controller and the ministry of health to really go through all the data, examine everything, to double check what we have done, what Oxford has done that is safe and effective,” Adar Poonawalla, CEO of SII.
A health worker takes part in a dry run or a mock drill for Covid-19 vaccine delivery at a model vaccination centre at Ansari Road in New Delhi.(Sanchit Khanna/HT Photo)
A health worker takes part in a dry run or a mock drill for Covid-19 vaccine delivery at a model vaccination centre at Ansari Road in New Delhi.(Sanchit Khanna/HT Photo)

Drug regulator gives final approval for Covid-19 vaccines of SII, Bharat Biotech

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON JAN 03, 2021 01:55 PM IST
Covaxin is the indigenous vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
People queue to register for coronavirus disease tests at Sector 30 District Hospital in Noida.(Sunil Ghosh / HT Photo)
People queue to register for coronavirus disease tests at Sector 30 District Hospital in Noida.(Sunil Ghosh / HT Photo)

India reports 18,177 Covid-19 cases, 217 deaths in 24 hours

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
UPDATED ON JAN 03, 2021 10:06 AM IST
The Union health ministry’s Covid-19 dashboard at 8am showed there were 20,923 recoveries between Saturday and Sunday morning.
A view showing the campus of Delhi's first Covid-19 vaccination centre set up in Srinivaspuri, New Delhi, India.(Amal KS/HT PHOTO)
A view showing the campus of Delhi's first Covid-19 vaccination centre set up in Srinivaspuri, New Delhi, India.(Amal KS/HT PHOTO)

Why India could catch up quickly on Covid vaccination

Hindustan Times, New Delhi | By HT Correspondent
UPDATED ON JAN 02, 2021 04:58 AM IST
With the manufacturing and stockpiling license, the Serum Institute of India has already been able to stockpile 75 million doses of the Oxford/AstraZeneca vaccine and by the first week of January, we will have 100 million doses.
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)
A healthcare worker make preparations inside a room at a vaccination center set up at a South Delhi Municipal Corp. maternity home ahead of a nationwide trial of a Covid-19 vaccine delivery system in New Delhi, India.(Bloomberg)

Happy Vaccine Year

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON JAN 02, 2021 04:32 AM IST
An SII official said on Thursday at a webinar that the company had already stockpiled 75 million doses. SII’s chief executive Adar Poonawalla on Wednesday said the company will be supplying India and Covax in a 50-50 manner as and when it produces vials.
A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport in New Delhi in this file photo.(Reuters Photo)
A ground staff walks past a container kept at the Cargo Terminal 2 of the Indira Gandhi International Airport in New Delhi in this file photo.(Reuters Photo)

From cargo planes to vans: Here’s how Centre plans to distribute Covid-19 vaccine

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
UPDATED ON JAN 01, 2021 08:58 AM IST
On Friday, the subject expert committee under the Central Drugs Standard Control Organisation will meet to consider the emergency-use authorisation application of Pfizer, Serum Institute of India (SII) and Bharat Biotech’s Covaxin.
The initial lots of the vaccine will be sent only to government hospitals, public health centres or large private hospitals. The first two priority groups—health care and other frontline workers
The initial lots of the vaccine will be sent only to government hospitals, public health centres or large private hospitals. The first two priority groups—health care and other frontline workers

Elaborate distribution plan on track as India awaits vaccine approval

Hindustan Times, New Delhi | By Saubhadra Chatterji
PUBLISHED ON DEC 31, 2020 11:31 PM IST
The vaccines will be stocked at four Government Medical Store Depots (in Karnal, Mumbai, Chennai and Kolkata) and state and regional vaccine stores.
India has a ‘robust plan’ for vaccination and is going to roll out vaccines for a large part of its population ‘in the near future’, AIIMS Delhi Director Dr Randeep Guleria said.(ANI photo)
India has a ‘robust plan’ for vaccination and is going to roll out vaccines for a large part of its population ‘in the near future’, AIIMS Delhi Director Dr Randeep Guleria said.(ANI photo)

India will have Covid-19 vaccine within days: AIIMS director

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Prashasti Singh
UPDATED ON DEC 31, 2020 09:06 AM IST
Pune-based SII has sought emergency approval for the vaccine--Covishield-- developed along with global pharma giant AstraZeneca and Oxford University.
Dr Harsh Vardhan inaugurated India’s first indigenous pneumococcal conjugate vaccine (PCV) developed by the Serum Institute of India to treat pneumonia in children.(Twitter/@MoHFW_INDIA)
Dr Harsh Vardhan inaugurated India’s first indigenous pneumococcal conjugate vaccine (PCV) developed by the Serum Institute of India to treat pneumonia in children.(Twitter/@MoHFW_INDIA)

India’s first indigenous pneumonia vaccine by SII launched

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Srivatsan K C
UPDATED ON DEC 28, 2020 09:21 PM IST
The pneumococcal conjugate vaccine (PCV) would be used to treat pneumonia in children and has been developed by SII in collaboration with other partners like the Bill and Melinda Gates Foundation, according to an official statement from the health ministry.
Men walk past a mural of frontline workers amid the spread of the coronavirus disease in Mumbai, India.(REUTERS)
Men walk past a mural of frontline workers amid the spread of the coronavirus disease in Mumbai, India.(REUTERS)

‘300 million doses by July’: SII chief Adar Poonawalla on Covishield

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Arpan Rai
UPDATED ON DEC 28, 2020 08:05 PM IST
Hinting at approval from British and Indian governments to approve shots for emergency use, Poonawalla said, “You will be hearing some good news from the UK very soon.”
SII, which is manufacturing and testing the Oxford-AstraZeneca coronavirus vaccine in India, last week had submitted additional data to the national drugs regulator that it had sought for its EUA application in its last meeting on December 9.(REUTERS)
SII, which is manufacturing and testing the Oxford-AstraZeneca coronavirus vaccine in India, last week had submitted additional data to the national drugs regulator that it had sought for its EUA application in its last meeting on December 9.(REUTERS)

Expert panel may convene this week to examine Oxford vaccine emergency-use authorisation

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON DEC 28, 2020 11:22 AM IST
It is likely that Oxford-AstraZeneca vaccine candidate may be the first anti-Covid-19 vaccine to be granted emergency-use approval in India
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture inside his office at the Serum Institute of India, in Pune.(REUTERS)
Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India poses for a picture inside his office at the Serum Institute of India, in Pune.(REUTERS)

Serum Institute submits more data for emergency use licence

Hindustan Times, New Delhi | By Rhythma Kaul
UPDATED ON DEC 23, 2020 05:40 AM IST
The meeting will also review data for the vaccine candidate by Pfizer, which too applied for emergency approval but sought more time when the last meeting was held on December 9.
India’s vaccine rollout will begin in first quarter of 2021 (January to March), with frontline healthcare workers and individuals over the age of 50 years gaining priority.(Ajay Aggarwal /HT PHOTO)
India’s vaccine rollout will begin in first quarter of 2021 (January to March), with frontline healthcare workers and individuals over the age of 50 years gaining priority.(Ajay Aggarwal /HT PHOTO)

India can inoculate priority groups against Covid by June 2021: Fitch Solutions

New Delhi | By Press Trust of India | Posted by Deepali Sharma
UPDATED ON DEC 21, 2020 07:25 PM IST
With a population of 130 crore (and 9.4 crore over 65-year-olds), the domestic vaccination drive will be the largest in the world.
Serum Institute of India (SII) chief executive officer Adar Poonawalla is seen in Pune in this file photo.(Shankar Narayan/HT Photo)
Serum Institute of India (SII) chief executive officer Adar Poonawalla is seen in Pune in this file photo.(Shankar Narayan/HT Photo)

Govt must protect vaccine makers against lawsuits: SII’s Adar Poonawalla

Hindustan Times, New Delhi | By hindustantimes.com | Edited by Meenakshi Ray
UPDATED ON DEC 19, 2020 10:29 AM IST
The government, Adar Poonawalla said, should bring a law as it would help companies focus on developing and manufacturing the vaccines rather than having to address legal issues.
Even with vaccines in hand, the rollouts will take many months, even in rich countries, and many developing ones are facing serious logistical challenges that will add to delays(REUTERS)
Even with vaccines in hand, the rollouts will take many months, even in rich countries, and many developing ones are facing serious logistical challenges that will add to delays(REUTERS)

Poor countries face long wait for vaccines despite promises

New Delhi | By Associated Press | Posted by Ayshee Bhaduri
UPDATED ON DEC 15, 2020 03:50 PM IST
The ambitious initiative known as COVAX created to ensure the entire world has access to Covid-19 vaccines has secured only a fraction of the 2 billion doses it hopes to buy over the next year, has yet to confirm any actual deals to ship out vaccines and is short on cash.
Bill Gates said by the summer of 2021, the rich countries may have more vaccine coverage than other countries.(REUTERS)
Bill Gates said by the summer of 2021, the rich countries may have more vaccine coverage than other countries.(REUTERS)

‘We may be back to normal in 2022’: Bill Gates

Hindustan Times, New Delhi | By R Sukumar
UPDATED ON DEC 11, 2020 10:30 AM IST
The conversation ranged from the development of vaccines to the stuttering progress of Gavi, the Vaccine Alliance’s Covax programme, which aims to ensure Covid-19 vaccines are accessible and affordable for poor countries, to the timing of the world’s return to normalcy.
SHARE
  • 1
  • 2
  • ...
Story Saved